Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Vasko

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Phase II trial of sorafenib in metastatic thyroid cancerRichard T Kloos, Matthew D Ringel, Michael V Knopp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancersTanios Bekaii-Saab, Mitch A Phelps, Xiaobai Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancerElaine T Lam, Matthew D Ringel, Richard T Kloos, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Phase II trial of sorafenib in metastatic thyroid cancerRichard T Kloos, Matthew D Ringel, Michael V Knopp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancersTanios Bekaii-Saab, Mitch A Phelps, Xiaobai Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancerElaine T Lam, Matthew D Ringel, Richard T Kloos, et al.
Pageof 3